| [1] |
LINDOR KD, BOWLUS CL, BOYER J, et al. Primary biliary cholangitis: 2018 practice guidance from the american association for the study of liver diseases[J]. Hepatology, 2019, 69(1): 394-419. DOI: 10.1002/hep.30145. |
| [2] |
SYLVESTRE PB, BATTS KP, BURGART LJ, et al. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history[J]. Liver Transpl, 2003, 9(10): 1086-1093. DOI: 10.1053/jlts.2003.50213. |
| [3] |
YOUNOSSI ZM, BERNSTEIN D, SHIFFMAN ML, et al. Diagnosis and management of primary biliary cholangitis[J]. Am J Gastroenterol, 2019, 114(1): 48-63. DOI: 10.1038/s41395-018-0390-3. |
| [4] |
MOLINA E, HERNANDEZ A. Clinical manifestations of primary hepatic angiosarcoma[J]. Dig Dis Sci, 2003, 48(4): 677-682. DOI: 10.1023/a:1022868221670. |
| [5] |
|
| [6] |
HUANG NC, WANN SR, CHANG HT, et al. Arsenic, vinyl chloride, viral hepatitis, and hepatic angiosarcoma: A hospital-based study and review of literature in Taiwan[J]. BMC Gastroenterol, 2011, 11: 142. DOI: 10.1186/1471-230X-11-142. |
| [7] |
|
| [8] |
CHAUDHARY P, BHADANA U, SINGH RA, et al. Primary hepatic angiosarcoma[J]. Eur J Surg Oncol, 2015, 41(9): 1137-1143. DOI: 10.1016/j.ejso.2015.04.022. |
| [9] |
ZHU YP, CHEN YM, MATRO E, et al. Primary hepatic angiosarcoma: A report of two cases and literature review[J]. World J Gastroenterol, 2015, 21(19): 6088-6096. DOI: 10.3748/wjg.v21.i19.6088. |
| [10] |
MESIANO S, FERRARA N, JAFFE RB. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization[J]. Am J Pathol, 1998, 153(4): 1249-1256. DOI: 10.1016/S0002-9440(10)65669-6. |
| [11] |
TAMSMA JT, KEIZER HJ, MEINDERS AE. Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited[J]. Ann Oncol, 2001, 12(10): 1353-1357. DOI: 10.1023/a:1012504904713. |
| [12] |
ISHAK KG, SESTERHENN IA, GOODMAN ZD, et al. Epithelioid hemangioendothelioma of the liver: A clinicopathologic and follow-up study of 32 cases[J]. Hum Pathol, 1984, 15(9): 839-852. DOI: 10.1016/s0046-8177(84)80145-8. |
| [13] |
STUDER LL, SELBY DM. Hepatic epithelioid hemangioendothelioma[J]. Arch Pathol Lab Med, 2018, 142(2): 263-267. DOI: 10.5858/arpa.2016-0171-RS. |
| [14] |
OHMOTO K, HIROKAWA M, TAKESUE M, et al. Hepatic angiosarcoma with early central enhancement and arterioportal shunt on dynamic CT[J]. Hepatogastroenterology, 2000, 47(36): 1717-1718. http://europepmc.org/abstract/MED/11149040 |
| [15] |
SHIMADA K, NAKAMOTO Y, ISODA H, et al. FDG PET for giant cavernous hemangioma: Important clue to differentiate from a malignant vascular tumor in the liver[J]. Clin Nucl Med, 2010, 35(12): 924-926. DOI: 10.1097/RLU.0b013e3181f9de11. |
| [16] |
|
| [17] |
ZHENG YW, ZHANG XW, ZHANG JL, et al. Primary hepatic angiosarcoma and potential treatment options[J]. J Gastroenterol Hepatol, 2014, 29(5): 906-911. DOI: 10.1111/jgh.12506. |
| [18] |
|
DownLoad:
